Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing Microvascular Dysfunction in Revascularized STEMI Patients by Off-target Properties of Ticagrelor
2014-005363-33Phase 4Completed
- Sponsor
- VU university medical center
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor in myocardial infarction (MI) (2 arms), sponsored by VU university medical center. Primary endpoint: Index of microcirculatory resistance in infarct-related vessel at 1 month. Started Apr 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2014-005363-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005363-33.